Work

Abstract 4143840: Transthyretin V142I Genetic Variant and Heart Failure Risk: A Multi-Institutional Analysis of US Million-Veteran Program (MVP)

Year: 2024

Type: conference-abstract

Source: Circulation

DOI: 10.1161/circ.150.suppl_1.4143840

Authors: Konstantinos Sideris, Lina Brinker, Tyler J. Nelson, Anthony Gao, Christos Kyriakopoulos, Kathryn Pridgen, Dan Berlowitz, Catherine Tcheandjieu, Scott Damrauer, Kyong-Mi Chang, LELAND HULL, Jacob Joseph, Jeffrey Ferraro, Fatai Y. Agiri, Steven Roblin, Craig Teerlink, Josef Stehlik, Spencer Carter, julie lynch

Institutions: University of Utah, VA Salt Lake City Healthcare System, Edith Nourse Rogers Memorial Veterans Hospital, University of California, San Francisco, Philadelphia VA Medical Center, Massachusetts General Hospital, Brown University, Alnylam Pharmaceuticals (United States)

Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404359471

Cites:

Cited by:

Related to: 10